Sort
39,280 grants matching “leukemia”
Nervous System Development and Plasticity
$1,039,324Richard Douglas Fields · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2010 · HD
Elicitation of HIV Broadly Neutralizing Antibodies from Engineered B cells
$1,039,249James Even Voss · Scripps Research Institute, The · R01 · FY2023 · AI
Cancer and Leukemia Group B-Leukemia Correlative Science
$1,039,188Ohio State University · U10 · FY2003 · CA
Cancer and Leukemia Group B-Leukemia Correlative Science
$1,039,188Ohio State University · U10 · FY2004 · CA
Reading mitochondrial apoptotic signaling to identify active cancer therapeutics
$1,038,996Anthony G Letai · Dana-Farber Cancer Inst · R35 · FY2022 · CA
Developing Therapeutics That Target RAD51 To Treat Leukemia and Lymphoma
$1,038,983Kevin D Mills · Cyteir Therapeutics, Inc. · R42 · FY2016 · CA
National Resource for Translational and Developmental Proteomics
$1,038,321Neil L Kelleher · Northwestern University · P41 · FY2016 · GM
Translating genomic discoveries to improved outcomes for high risk acute leukemia
$1,037,401Charles G. Mullighan · St. Jude Children'S Research Hospital · R35 · FY2024 · CA
Reading mitochondrial apoptotic signaling to identify active cancer therapeutics
$1,037,388Anthony G Letai · Dana-Farber Cancer Inst · R35 · FY2021 · CA
Mechanistic and translational studies of CBF leukemia
$1,036,899Pu Paul Liu · National Human Genome Research Institute · ZIA · FY2017 · HG
Metabolic basis of B cell lineage leukemia relapse
$1,036,898Markus Mãschen · Beckman Research Institute/City Of Hope · R35 · FY2017 · CA
Receptor Mediated Erythropoietin Metabolic Response
$1,036,882Constance Noguchi · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2025 · DK
Development of Recombinant Toxins to Treat Hematologic Malignancies
$1,036,808Robert Kreitman · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Molecular Basis for the Pathogenesis of Murine Retroviruses
$1,036,246Sandra K Ruscetti · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
The 10,000 Families Cohort: a new study to understand the environmental causes of cancer
$1,036,207Jenny N. Poynter · University Of Minnesota · UG3 · FY2022 · CA
Metabolic basis of B cell lineage leukemia relapse
$1,035,561Markus Mãschen · Beckman Research Institute/City Of Hope · R35 · FY2018 · CA
Proteolytic disregulation of the S326C mutant OGG1 DNA repair enzyme
$1,035,049Michele K Evans · National Institute On Aging · ZIA · FY2011 · AG
Metabolic basis of B cell lineage leukemia relapse
$1,035,016Markus Mãschen · Beckman Research Institute/City Of Hope · R35 · FY2020 · CA
Genetic Approaches To Understanding Organ Development and Function
$1,034,894Lothar Hennighausen · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2010 · DK
Understanding and Targeting Aberrant RNA Splicing in Leukemia
$1,034,176Omar Abdel-Wahab · Sloan-Kettering Inst Can Research · R35 · FY2025 · CA
Identifying the Cellular and Molecular Targets of JAK/STAT-Driven Adipose Wasting to Reverse Cancer Cachexia
$1,033,521Rodney E Infante · Ut Southwestern Medical Center · R01 · FY2025 · CA
Clinical Trials of Patients with AIDS-Related Malignancies
$1,033,298Robert Yarchoan · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Mechanisms of treatment failure in chimeric antigen receptor T cell therapy
$1,032,791Brian Till · Fred Hutchinson Cancer Research Center · R01 · FY2021 · CA
Zebrafish Models of Cancer
$1,031,640Dennis D Hickstein · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Targeting Agents for Human and Canine Lymphoma
$1,031,038Kit S Lam · University Of California At Davis · U19 · FY2008 · CA